| Citation: |
LI Weiwei, QIAN Xiangyun, ZHANG Ji, LU Hui. Impact of nausea-free management program based on shared decision-making on nausea and vomiting after transarterial chemoembolization in liver cancer patients[J]. Journal of Clinical Medicine in Practice, 2025, 29(7): 113-117, 126. DOI: 10.7619/jcmp.20243419
|
To explore the impact of nausea and vomiting management program based on shared decision-making on post-transarterial chemoembolization (TACE) nausea and vomiting in liver cancer patients.
A shared decision-making aid was designed, and nausea and vomiting management program was developed. A total of 100 liver cancer patients who underwent TACE treatment in the Department of Interventional Radiology at Nantong Third People's Hospital from January to December 2023 were selected as study subjects. The control group (admitted from January to June 2023) received routine TACE perioperative nursing care, while the experimental group (admitted from July to December 2023) implemented the nausea and vomiting management program in addition to routine care. The incidence and severity of nausea and vomiting within 24 hours post-surgery, as well as the vomiting-related functional living index, quality of life, and self-efficacyin decision-making before and after the intervention were compared between the two groups.
Within 24 hours post-surgery, the incidence and severity of nausea and vomiting in the experimental group were lower than those in the control group, with statistically significant differences (P < 0.05). After the intervention, the total and dimensional scores of the Quality of Life in Liver Cancer (QOL-LC) scale and the vomiting-related functional living index in the experimental group were higher than those in the control group(P < 0.05). Additionally, the self-decision-making efficacy score in the experimental group was higher after the intervention than before intervention and higher than that in the control group (P < 0.05).
The nausea and vomiting management program based on shared decision-making can effectively reduce the incidence and severity of post-TACE nausea and vomiting in liver cancer patients, and improve their quality of life, vomiting-related functional living index, and self-decision-making efficacy.
| [1] |
芦炜南, 刘兆玉. 以载药微球CalliSpheres栓塞治疗不可切除原发性肝癌[J]. 中国介入影像与治疗学, 2020, 17(7): 389-392.
|
| [2] |
杨海明, 孙世蒙, 于海东, 等. TACE联合氩氦刀冷冻治疗中晚期原发性肝癌的安全性和疗效分析[J]. 实用放射学杂志, 2019, 35(3): 444-447.
|
| [3] |
何璐, 黄朝意, 曾洋帆, 等. 肝癌患者介入术后早期恶心呕吐现状及影响因素分析[J]. 护理学杂志, 2022, 37(23): 50-52, 62.
|
| [4] |
汪洋, 任海玲, 孙英杰, 等. 无呕吐规范化病房护理工作模式在肿瘤内科的应用探讨[J]. 护士进修杂志, 2016, 31(22): 2048-2051.
|
| [5] |
谭蕾, 刘翔宇, 韦迪, 等. 肺癌化疗无呕病房护理工作模式的建立与成效[J]. 中国护理管理, 2017, 17(2): 244-248. doi: 10.3969/j.issn.1672-1756.2017.02.024
|
| [6] |
周小英, 张雯, 张岩, 等. 原发性肝癌介入手术病人自我管理效能感的影响因素分析[J]. 护理研究, 2022, 36(10): 1857-1860.
|
| [7] |
郑红颖, 胡嘉乐, 董柏君, 等. 医护患共享决策相关理论模式的研究进展[J]. 中国护理管理, 2018, 18(11): 1575-1580.
|
| [8] |
赵剑波, 李彦豪, 陈勇, 等. 原发性肝癌患者介入治疗后生命质量得分的变化分析[J]. 临床放射学杂志, 2002, 21(7): 550-552.
|
| [9] |
王思潼, 叶志霞, 李芸芸, 等. 中文版决策自我效能量表在原发性肝癌患者治疗决策中的信效度检验[J]. 解放军护理杂志, 2021, 38(1): 37-40, 64.
|
| [10] |
邢颖, 钟志强, 刘峥嵘, 等. 肝恶性肿瘤介入治疗的评估和方案[J]. 中国临床医生杂志, 2022, 50(5): 521-523.
|
| [11] |
杨建芬, 沈永奇. 肿瘤化疗相关性恶心呕吐的防治进展[J]. 中国当代医药, 2019, 26(15): 32-35.
|
| [12] |
翁飞燕, 黄兹丽, 符冰. 肝癌介入术后不良反应的个性化护理干预[J]. 实用临床医药杂志, 2016, 20(10): 45-47. doi: 10.7619/jcmp.201610015
|
| [13] |
王聃, 于倩, 王亚华, 等. 四花穴隔药灸联合格拉司琼治疗原发性肝癌患者介入术后恶心呕吐的临床研究[J]. 中西医结合肝病杂志, 2020, 30(3): 224-226.
|
| [14] |
向贵, 蔡艳珠, 汪婷, 等. 循证护理在肝癌介入栓塞术后并发症的预防和生活质量分析[J]. 长春中医药大学学报, 2020, 36(1): 148-151.
|
| [15] |
GU J, LIANG Y. Clinical nursing paths benefit patient outcomes undergoing transcatheter arterial chemoembolization for hepatocellular carcinoma[J]. Evid Based Complement Alternat Med, 2022, 2022: 4655293.
|
| [16] |
KIM M S, UHM J Y. Impact of discriminant factors on the comfort-care of nurses caring for trans-arterial chemoembolisation patients[J]. Support Care Cancer, 2022, 30(9): 7773-7781.
|
| [17] |
薛幼华, 芮冶昊, 黄薛菲, 等. 快速康复理念在肝癌患者行肝动脉化疗栓塞中的应用[J]. 介入放射学杂志, 2016, 25(1): 78-80.
|
| [18] |
YUAN Y, LI Y W, YANG G X, et al. Effect of comprehensive nursing approach in perioperative stage of patients with hepatocellular carcinoma interventional therapy[J]. Evid Based Complement Alternat Med, 2022, 2022: 6862463.
|
| [19] |
何好好, 贺彩芳, 章若锦, 等. 肝癌介入术后基于微信平台的垂直护理模式的研究及效果评价[J]. 介入放射学杂志, 2018, 27(10): 983-985.
|
| [20] |
NCCN. Clinical Practice Guidelines in Oncology: Antiemesis[EB/OL]. (2014-02-25)[2024-07-10]. http://www.Nccn.org/professionals/physician_gls/pdf/antiemesis.
|
| [21] |
中国抗癌协会癌症康复与姑息治疗专业委员会, 中国临床肿瘤学会抗肿瘤药物安全管理专家委员会. 肿瘤治疗相关呕吐防治指南(2014版)[J]. 临床肿瘤学杂志, 2014, 19(3): 263-273.
|
| [22] |
上海市抗癌协会癌症康复与姑息专业委员会. 化疗所致恶心呕吐全程管理上海专家共识(2018年版)[J]. 中国癌症杂志, 2018, 28(12): 946-960.
|
| 1. |
范骏，魏可，骆金华，薛磊. 血清微小RNA-184、微小RNA-451a表达对Ⅰ～ⅡA期非小细胞肺癌根治术后复发转移的预测价值. 实用临床医药杂志. 2024(13): 1-6 .
 本站查看
| |
| 2. |
居承辉，史雨晨. 外周血淋巴细胞亚群在非小细胞肺癌患者中的表达情况. 中外医学研究. 2024(25): 83-86 .
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: